0.32 USD
↘ 0.02 (5.60%)AT CLOSE (11:59 AM EDT)
Theriva Biologics, Inc.
TOVXAMEX • USD
0.33
↗ 0.01 (3.45%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.33
↗ 0.01 (3.45%)
Market: CLOSED
Open?$0.33
High?$0.34
Low?$0.32
Prev. Close?$0.34
Volume?2.1M
Avg. Volume?32.0M
VWAP?$0.34
Rel. Volume?0.07x
Bid / Ask
Bid?$0.33 × 500
Ask?$0.33 × 900
Spread?$0.00
Midpoint?$0.33
Valuation & Ratios
Market Cap?15.6M
Shares Out?45.9M
Float?45.6M
Float %?99.3%
P/E Ratio?N/A
P/B Ratio?1.01
EPS?-$0.50
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
Employees
16
Market Cap
15.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1993-04-05
Address
9605 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
Phone: (734) 332-7800
ROCKVILLE, MD 20850
Phone: (734) 332-7800
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.63Adequate
Quick Ratio?1.63Adequate
Cash Ratio?1.41Strong
Debt/Equity?0.11Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?1.01CHEAP▾
P/S?52.01HIGH▾
P/FCF?N/A▾
EV/EBITDA?-0.1CHEAP▾
EV/Sales?9.45HIGH▾
Returns & Efficiency
ROE?-149.2%WEAK▾
ROA?-60.1%WEAK▾
Cash Flow & Enterprise
FCF?$-14404000
Enterprise Value?$2.8M
Fundamentals ratios updated end of day